Stockreport

Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Reviva Pharmaceuticals Holdings, Inc.  (RVPH) 
PDF – 108 patients have completed 1-year of treatment in 1-year open-label extension (OLE) trial – – Vocal biomarker speech latency data from RECOVER trial reinforce brilar [Read more]